Ubon Bio Ethanol Plc (UBE), a manufacturer of cassava-based products, expects its revenue to grow by 10% this year thanks to higher prices of ethanol and flour both domestically and overseas.
Greater efforts to cultivate globally competitive local businesses could be a productive approach to improve the Thai economy ...
Facing charges from the Securities and Exchange Commission for misleading claims related to a controversial Alzheimer’s drug candidate, Cassava Sciences and two of the company’s former ...
In our series of letters from African journalists, Ghanaian Elizabeth Ohene considers the call of Uganda's President Yoweri Museveni for people to eat the humble cassava as the price of wheat ...
Cassava Sciences and its executives agreed to pay $40 million in penalties for misleading investors. Dr. Wang, a consultant, manipulated clinical trial data, leading to misleading Alzheimer's ...
For nearly a year, my stance on Cassava Sciences and its Alzheimer’s disease drug candidate simufilam has been clear: Emerging evidence shows the drug is inert, and patients with Alzheimer’s ...
That was a far steeper fall than the 0.2% sag of the S&P 500 index on the day. Before market open, Cassava announced that it has reached agreement with the U.S. Securities and Exchange Commission ...
Alzheimer’s drug developer Cassava Sciences agreed Thursday to pay $40 million to settle regulatory claims that it misled investors about the results of a clinical trial that showed promise for ...
SEC Charges Cassava Sciences Over Manipulated Alzheimer's Trial Data, Company And Former Execs Agree To Pay Penalty Cassava Sciences and its executives face a $40 million SEC settlement over ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Kalamay varies in color from light brown to deep, dark purple, depending on the type of sugar used and if additional ingredients like ube (purple yam ... Kabkab, also known as cabcab or cassava ...
Alzheimer's drug developer Cassava Sciences (NASDAQ:SAVA) has struck a consulting agreement with its former chief executive officer, Remi Barbier, nearly two months after his resignation.